Saccharomyces cerevisiae β-Carbonic Anhydrase: Inhibition and Activation Studies

被引:20
作者
Isik, Semra [3 ]
Guler, Ozen Ozensoy [3 ]
Kockar, Feray [1 ]
Aydin, Meltem [1 ]
Arslan, Oktay [3 ]
Supuran, Claudiu T. [2 ]
机构
[1] Balikesir Univ, Sci & Art Fac, Dept Biol, Balikesir, Turkey
[2] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[3] Balikesir Univ, Sci & Art Fac, Dept Chem, Balikesir, Turkey
关键词
Carbonic anhydrase; beta-class enzyme; Saccharomyces cerevisiae; yeast; sulfonamide; sulfamate; anion inhibitor; amino acid; amine; activator; PATHOGENS CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; CRYSTALLOGRAPHIC ANALYSIS; CLASS ENZYMES; ACTIVE-SITE; GENE NCE103; ISOFORM-II; ISOZYME-II; CLASS CAB; CO2;
D O I
10.2174/138161210793429878
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta-carbonic anhydrase from Saccharomyces cerevisiae (CA, EC 4.2.1.1), scCA, which is encoded by the Nce103 gene, is an effective catalyst for CO2 hydration to bicarbonate and protons, with a k(cat) of 9.4 x 10(5) s(-1), and k(cat)/K-M of 9.8 x 10(7) M-1.s(-1). Its inhibition with anions and sulfonamides has been investigated, as well as its activation with amines and amino acids. Bromide, iodide and sulfamide, were the best anion inhibitors, with K(I)s of 8.7 - 10.8 mu M. Benzenesulfonamides substituted in 2-, 4- and 3,4-positions with amino, alkyl, halogeno and hydroxyalkyl moieties had K(I)s in the range of 0.976 - 18.45 mu M. Better inhibition (K(I)s in the range of 154 654 nM) was observed for benzenesulfonamides incorporating aminoalkyl/carboxyalkyl moieties or halogenosulfanilamides; benzene-1,3-disulfonamides; simple heterocyclic sulfonamides and sulfanilyl-sulfonamides. The clinically used sulfonamides/sulfamate (acetazolamide, ethoxzolamide, methazolamide, dorzolamide, topiramate, celecoxib, etc.) generally showed effective scCA inhibitory activity, with K(I)s in the range of 82.6 - 133 nM. The best inhibitor (K-I of 15.1 nM) was 4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide. L-adrenaline and some piperazines incorporating aminoethyl moieties were the most effective scCA activators. These studies may lead to a better understanding of the role of this enzyme in yeasts/fungi, and since the Nce103 gene is also present in many pathogenic organisms (Candida spp., Cryptococcus neoformans, etc) they may be useful to develop antifungal drugs.
引用
收藏
页码:3327 / 3336
页数:10
相关论文
共 50 条
  • [31] Sulfonamide inhibition studies of two β-carbonic anhydrases from the ascomycete fungus Sordaria macrospora, CAS1 and CAS2
    Vullo, Daniela
    Lehneck, Ronny
    Poeggeler, Stefanie
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 390 - 396
  • [32] Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides
    Vullo, Daniela
    Leewattanapasuk, Worraanong
    Muehlschlegel, Fritz A.
    Mastrolorenzo, Antonio
    Capasso, Clemente
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2647 - 2652
  • [33] Carbonic anhydrase inhibitors. Inhibition of the fungal β-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids
    Innocenti, Alessio
    Winum, Jean-Yves
    Hall, Rebecca A.
    Muehlschlegel, Fritz A.
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2642 - 2645
  • [34] Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
    Del Prete, Sonia
    Vullo, Daniela
    De Luca, Viviana
    Carginale, Vincenzo
    Ferraroni, Marta
    Osman, Sameh M.
    AlOthman, Zeid
    Supuran, Claudiu T.
    Capasso, Clemente
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (05) : 1115 - 1120
  • [35] Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
    Vullo, Daniela
    Kumar, R. Siva Sai
    Scozzafava, Andrea
    Ferry, James G.
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 33 (01) : 31 - 36
  • [36] Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosis
    Nishimori, Isao
    Minakuchi, Tomoko
    Vullo, Daniela
    Scozzafava, Andrea
    Innocenti, Alessio
    Supuran, Claudiu T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 3116 - 3120
  • [37] Activation studies of the β-carbonic anhydrases fromEscherichia coliwith amino acids and amines
    Nocentini, Alessio
    Del Prete, Sonia
    Mastrolorenzo, Margaret D.
    Donald, William A.
    Capasso, Clemente
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1379 - 1386
  • [38] Carbonic anhydrase inhibitors:: Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies
    Krungkrai, Jerapan
    Krungkrai, Sudaratana R.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5466 - 5471
  • [39] Activation studies of the β-carbonic anhydrases from Malassezia restricta with amines and amino acids
    Angeli, Andrea
    Prete, Sonia Del
    Ghobril, Cynthia
    Hitce, Julien
    Clavaud, Cecile
    Marrat, Xavier
    Donald, William A.
    Capasso, Clemente
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 824 - 830
  • [40] Carbonic anhydrase inhibitors: Cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides
    Nishimori, Isao
    Minakuchi, Tomoko
    Onishi, Saburo
    Vullo, Daniela
    Cecchi, Alessandro
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (23) : 7229 - 7236